A new study shows that pairing two existing medications can reverse fatty liver buildup and may also cut cardiovascular risk. Credit: Shutterstock Metabolic dysfunction-associated steatotic liver disease is now the most common liver condition worldwide, affecting about one in three adults. It develops when excess fat builds up inside liver cells, which can lead to serious liver damage and also increases the risk of dying from heart and blood vessel disease. A recent study from the University of